Design, synthesis and evaluation of benzothiazole derivatives as multifunctional agents. 2020

Ernestine Nicaise Djuidje, and Sabrina Sciabica, and Raissa Buzzi, and Valeria Dissette, and Jan Balzarini, and Sandra Liekens, and Elena Serra, and Elisa Andreotti, and Stefano Manfredini, and Silvia Vertuani, and Anna Baldisserotto
Department of Life Sciences and Biotechnology, Master Course in Cosmetic Science and Technologies, University of Ferrara, via L. Borsari 46, 44121 Ferrara, Italy.

Oxidative stress is the product or aetiology of various multifactorial diseases; on the other hand, the development of multifunctional compounds is a recognized strategy for the control of complex diseases. To this end, a series of benzothiazole derivatives was synthesized and evaluated for their multifunctional effectiveness as antioxidant, sunscreen (filter), antifungal and antiproliferative agents. Compounds were easily synthesized via condensation reaction between 2-aminothiophenols and different benzaldehydes. SAR study, particularly in position 2 and 6 of benzothiazoles, led to the identification of 4g and 4k as very interesting potential compounds for the design of multifunctional drugs. In particular, compound 4g is the best blocker of hERG potassium channels expressed in HEK 293 cells exhibiting 60.32% inhibition with IC50 = 4.79 μM.

UI MeSH Term Description Entries
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D052160 Benzothiazoles Compounds with a benzene ring fused to a thiazole ring.
D057809 HEK293 Cells A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5. 293T Cells,HEK 293 Cell Line,HEK 293 Cells,Human Embryonic Kidney Cell Line 293,Human Kidney Cell Line 293,293 Cell, HEK,293 Cells, HEK,293T Cell,Cell, 293T,Cell, HEK 293,Cell, HEK293,Cells, 293T,Cells, HEK 293,Cells, HEK293,HEK 293 Cell,HEK293 Cell

Related Publications

Ernestine Nicaise Djuidje, and Sabrina Sciabica, and Raissa Buzzi, and Valeria Dissette, and Jan Balzarini, and Sandra Liekens, and Elena Serra, and Elisa Andreotti, and Stefano Manfredini, and Silvia Vertuani, and Anna Baldisserotto
June 2017, Molecules (Basel, Switzerland),
Ernestine Nicaise Djuidje, and Sabrina Sciabica, and Raissa Buzzi, and Valeria Dissette, and Jan Balzarini, and Sandra Liekens, and Elena Serra, and Elisa Andreotti, and Stefano Manfredini, and Silvia Vertuani, and Anna Baldisserotto
November 2021, Chemistry & biodiversity,
Ernestine Nicaise Djuidje, and Sabrina Sciabica, and Raissa Buzzi, and Valeria Dissette, and Jan Balzarini, and Sandra Liekens, and Elena Serra, and Elisa Andreotti, and Stefano Manfredini, and Silvia Vertuani, and Anna Baldisserotto
February 2018, MedChemComm,
Ernestine Nicaise Djuidje, and Sabrina Sciabica, and Raissa Buzzi, and Valeria Dissette, and Jan Balzarini, and Sandra Liekens, and Elena Serra, and Elisa Andreotti, and Stefano Manfredini, and Silvia Vertuani, and Anna Baldisserotto
July 2005, Bioorganic & medicinal chemistry letters,
Ernestine Nicaise Djuidje, and Sabrina Sciabica, and Raissa Buzzi, and Valeria Dissette, and Jan Balzarini, and Sandra Liekens, and Elena Serra, and Elisa Andreotti, and Stefano Manfredini, and Silvia Vertuani, and Anna Baldisserotto
February 2019, European journal of medicinal chemistry,
Ernestine Nicaise Djuidje, and Sabrina Sciabica, and Raissa Buzzi, and Valeria Dissette, and Jan Balzarini, and Sandra Liekens, and Elena Serra, and Elisa Andreotti, and Stefano Manfredini, and Silvia Vertuani, and Anna Baldisserotto
December 2021, Journal of enzyme inhibition and medicinal chemistry,
Ernestine Nicaise Djuidje, and Sabrina Sciabica, and Raissa Buzzi, and Valeria Dissette, and Jan Balzarini, and Sandra Liekens, and Elena Serra, and Elisa Andreotti, and Stefano Manfredini, and Silvia Vertuani, and Anna Baldisserotto
August 2023, Drug development research,
Ernestine Nicaise Djuidje, and Sabrina Sciabica, and Raissa Buzzi, and Valeria Dissette, and Jan Balzarini, and Sandra Liekens, and Elena Serra, and Elisa Andreotti, and Stefano Manfredini, and Silvia Vertuani, and Anna Baldisserotto
May 2014, Bioorganic & medicinal chemistry letters,
Ernestine Nicaise Djuidje, and Sabrina Sciabica, and Raissa Buzzi, and Valeria Dissette, and Jan Balzarini, and Sandra Liekens, and Elena Serra, and Elisa Andreotti, and Stefano Manfredini, and Silvia Vertuani, and Anna Baldisserotto
November 2016, European journal of medicinal chemistry,
Ernestine Nicaise Djuidje, and Sabrina Sciabica, and Raissa Buzzi, and Valeria Dissette, and Jan Balzarini, and Sandra Liekens, and Elena Serra, and Elisa Andreotti, and Stefano Manfredini, and Silvia Vertuani, and Anna Baldisserotto
February 2016, Molecules (Basel, Switzerland),
Copied contents to your clipboard!